Clinical Trial Detail

NCT ID NCT01966289
Title SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

colon cancer

rectum cancer

Therapies

Cyclophosphamide

Guadecitabine

GVAX colorectal cancer vaccine

Age Groups: adult

No variant requirements are available.